$37.15
-0.75[-1.98%]
At close: Apr 18
$37.15
0[0.00%]
After Hours: 4:00PM EDT
Soleno Therapeutics
(NASDAQ:SLNO)Soleno Therapeutics Stock (NASDAQ:SLNO), Analyst Ratings, Price Targets, Predictions
Soleno Therapeutics Inc has a consensus price target of $55.6, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, Stifel, and Oppenheimer on February 5, 2024, January 23, 2024, and January 2, 2024. With an average price target of $67.67 between Piper Sandler, Stifel, and Oppenheimer, there's an implied 82.14% upside for Soleno Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Stifel
Oppenheimer
Guggenheim
Cantor Fitzgerald
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Soleno Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/05/2024 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | 150.34% | Piper Sandler | Yasmeen Rahimi | → $93 | Initiates | → Overweight | Get Alert |
| 01/23/2024 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | 69.58% | Stifel | Dae Gon Ha | → $63 | Initiates | → Buy | Get Alert |
| 01/02/2024 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | 26.51% | Oppenheimer | Leland Gershell | $44 → $47 | Maintains | Outperform | Get Alert |
| 11/21/2023 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | 7.67% | Guggenheim | Debjit Chattopadhyay | → $40 | Assumes | → Buy | Get Alert |
| 09/26/2023 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | -5.79% | Cantor Fitzgerald | Kristen Kluska | $19 → $35 | Maintains | Overweight | Get Alert |
| 09/15/2023 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | -62.31% | Oppenheimer | Leland Gershell | $8 → $14 | Maintains | Outperform | Get Alert |
| 08/31/2023 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | -48.86% | Cantor Fitzgerald | Kristen Kluska | → $19 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | -48.86% | Cantor Fitzgerald | Kristen Kluska | → $19 | Initiates | → Overweight | Get Alert |
| 05/25/2023 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | -78.47% | Oppenheimer | Leland Gershell | → $8 | Reiterates | → Outperform | Get Alert |
| 03/24/2023 | SLNO | Buy Now | Soleno Therapeutics | $37.15 | -78.47% | Oppenheimer | Leland Gershell | → $8 | Reiterates | → Outperform | Get Alert |
FAQ
What is the target price for Soleno Therapeutics (SLNO)?
The latest price target for Soleno Therapeutics (NASDAQ: SLNO) was reported by Piper Sandler on February 5, 2024. The analyst firm set a price target for $93.00 expecting SLNO to rise to within 12 months (a possible 150.34% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Soleno Therapeutics (SLNO)?
The latest analyst rating for Soleno Therapeutics (NASDAQ: SLNO) was provided by Piper Sandler, and Soleno Therapeutics initiated their overweight rating.
When was the last upgrade for Soleno Therapeutics (SLNO)?
There is no last upgrade for Soleno Therapeutics.
When was the last downgrade for Soleno Therapeutics (SLNO)?
There is no last downgrade for Soleno Therapeutics.
When is the next analyst rating going to be posted or updated for Soleno Therapeutics (SLNO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Soleno Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Soleno Therapeutics was filed on February 5, 2024 so you should expect the next rating to be made available sometime around February 5, 2025.
Is the Analyst Rating Soleno Therapeutics (SLNO) correct?
While ratings are subjective and will change, the latest Soleno Therapeutics (SLNO) rating was a initiated with a price target of $0.00 to $93.00. The current price Soleno Therapeutics (SLNO) is trading at is $37.15, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.